SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 on the OPHELIA Study: Olaparib + Trastuzumab in HER2+ BRCAm Advanced Breast Cancer Patients
By
SABCS 2022 Conference Coverage
FEATURING
José Martínez
By
SABCS 2022 Conference Coverage
FEATURING
José Martínez
183 views
January 5, 2023
Login to view comments.
Click here to Login
Videos